Autoimmune Disease Diagnostics Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Autoimmune Disease Diagnostics Market Size Analysis

Global Autoimmune Disease Diagnostics Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Assay Kits & Consumables
  1. By Value
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Diseases
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. S2 Systemic Lupus Erythematosus
    1. S2 Systemic Lupus Erythematosus By Value
  4. Scleroderma
    1. Scleroderma By Value
  5. Vasculitis
    1. Vasculitis By Value
  6. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  7. Other Diseases
    1. Other Diseases By Value
  8. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  9. Autoimmune Thyroid Diseases
    1. Autoimmune Thyroid Diseases By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassays
  1. By Value
3. Indirect Immunofluorescence
  1. By Value
4. Multiplex Assays
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Point-of-Care Testing
  1. By Value
7. Other Technology
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. Other End Users
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Assay Kits & Consumables
  1. By Value
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Diseases
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. S2 Systemic Lupus Erythematosus
    1. S2 Systemic Lupus Erythematosus By Value
  4. Scleroderma
    1. Scleroderma By Value
  5. Vasculitis
    1. Vasculitis By Value
  6. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  7. Other Diseases
    1. Other Diseases By Value
  8. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  9. Autoimmune Thyroid Diseases
    1. Autoimmune Thyroid Diseases By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassays
  1. By Value
3. Indirect Immunofluorescence
  1. By Value
4. Multiplex Assays
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Point-of-Care Testing
  1. By Value
7. Other Technology
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. Other End Users
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Assay Kits & Consumables
    1. By Value
2. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Diseases
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. S2 Systemic Lupus Erythematosus
      1. S2 Systemic Lupus Erythematosus By Value
    4. Scleroderma
      1. Scleroderma By Value
    5. Vasculitis
      1. Vasculitis By Value
    6. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    7. Other Diseases
      1. Other Diseases By Value
    8. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    9. Autoimmune Thyroid Diseases
      1. Autoimmune Thyroid Diseases By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassays
    1. By Value
  3. Indirect Immunofluorescence
    1. By Value
  4. Multiplex Assays
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Point-of-Care Testing
    1. By Value
  7. Other Technology
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Laboratories
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. Other End Users
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Assay Kits & Consumables
  1. By Value
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Diseases
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. S2 Systemic Lupus Erythematosus
    1. S2 Systemic Lupus Erythematosus By Value
  4. Scleroderma
    1. Scleroderma By Value
  5. Vasculitis
    1. Vasculitis By Value
  6. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  7. Other Diseases
    1. Other Diseases By Value
  8. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  9. Autoimmune Thyroid Diseases
    1. Autoimmune Thyroid Diseases By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassays
  1. By Value
3. Indirect Immunofluorescence
  1. By Value
4. Multiplex Assays
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Point-of-Care Testing
  1. By Value
7. Other Technology
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. Other End Users
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Assay Kits & Consumables
    1. By Value
2. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Diseases
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. S2 Systemic Lupus Erythematosus
      1. S2 Systemic Lupus Erythematosus By Value
    4. Scleroderma
      1. Scleroderma By Value
    5. Vasculitis
      1. Vasculitis By Value
    6. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    7. Other Diseases
      1. Other Diseases By Value
    8. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    9. Autoimmune Thyroid Diseases
      1. Autoimmune Thyroid Diseases By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassays
    1. By Value
  3. Indirect Immunofluorescence
    1. By Value
  4. Multiplex Assays
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Point-of-Care Testing
    1. By Value
  7. Other Technology
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Laboratories
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. Other End Users
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Assay Kits & Consumables
  1. By Value
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Diseases
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. S2 Systemic Lupus Erythematosus
    1. S2 Systemic Lupus Erythematosus By Value
  4. Scleroderma
    1. Scleroderma By Value
  5. Vasculitis
    1. Vasculitis By Value
  6. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  7. Other Diseases
    1. Other Diseases By Value
  8. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  9. Autoimmune Thyroid Diseases
    1. Autoimmune Thyroid Diseases By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassays
  1. By Value
3. Indirect Immunofluorescence
  1. By Value
4. Multiplex Assays
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Point-of-Care Testing
  1. By Value
7. Other Technology
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. Other End Users
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Assay Kits & Consumables
    1. By Value
2. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Diseases
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. S2 Systemic Lupus Erythematosus
      1. S2 Systemic Lupus Erythematosus By Value
    4. Scleroderma
      1. Scleroderma By Value
    5. Vasculitis
      1. Vasculitis By Value
    6. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    7. Other Diseases
      1. Other Diseases By Value
    8. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    9. Autoimmune Thyroid Diseases
      1. Autoimmune Thyroid Diseases By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassays
    1. By Value
  3. Indirect Immunofluorescence
    1. By Value
  4. Multiplex Assays
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Point-of-Care Testing
    1. By Value
  7. Other Technology
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Laboratories
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. Other End Users
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Assay Kits & Consumables
  1. By Value
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Diseases
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. S2 Systemic Lupus Erythematosus
    1. S2 Systemic Lupus Erythematosus By Value
  4. Scleroderma
    1. Scleroderma By Value
  5. Vasculitis
    1. Vasculitis By Value
  6. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  7. Other Diseases
    1. Other Diseases By Value
  8. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  9. Autoimmune Thyroid Diseases
    1. Autoimmune Thyroid Diseases By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassays
  1. By Value
3. Indirect Immunofluorescence
  1. By Value
4. Multiplex Assays
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Point-of-Care Testing
  1. By Value
7. Other Technology
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. Other End Users
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Assay Kits & Consumables
    1. By Value
2. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Diseases
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. S2 Systemic Lupus Erythematosus
      1. S2 Systemic Lupus Erythematosus By Value
    4. Scleroderma
      1. Scleroderma By Value
    5. Vasculitis
      1. Vasculitis By Value
    6. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    7. Other Diseases
      1. Other Diseases By Value
    8. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    9. Autoimmune Thyroid Diseases
      1. Autoimmune Thyroid Diseases By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassays
    1. By Value
  3. Indirect Immunofluorescence
    1. By Value
  4. Multiplex Assays
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Point-of-Care Testing
    1. By Value
  7. Other Technology
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Laboratories
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. Other End Users
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Assay Kits & Consumables
  1. By Value
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Diseases
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. S2 Systemic Lupus Erythematosus
    1. S2 Systemic Lupus Erythematosus By Value
  4. Scleroderma
    1. Scleroderma By Value
  5. Vasculitis
    1. Vasculitis By Value
  6. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  7. Other Diseases
    1. Other Diseases By Value
  8. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  9. Autoimmune Thyroid Diseases
    1. Autoimmune Thyroid Diseases By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassays
  1. By Value
3. Indirect Immunofluorescence
  1. By Value
4. Multiplex Assays
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Point-of-Care Testing
  1. By Value
7. Other Technology
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. Other End Users
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Assay Kits & Consumables
    1. By Value
2. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Diseases
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. S2 Systemic Lupus Erythematosus
      1. S2 Systemic Lupus Erythematosus By Value
    4. Scleroderma
      1. Scleroderma By Value
    5. Vasculitis
      1. Vasculitis By Value
    6. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    7. Other Diseases
      1. Other Diseases By Value
    8. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    9. Autoimmune Thyroid Diseases
      1. Autoimmune Thyroid Diseases By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassays
    1. By Value
  3. Indirect Immunofluorescence
    1. By Value
  4. Multiplex Assays
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Point-of-Care Testing
    1. By Value
  7. Other Technology
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Laboratories
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. Other End Users
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Autoimmune Disease Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Hoffmann‑La Roche Ltd
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Abbott Laboratories
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Bio‑Rad Laboratories, Inc.
Beckman Coulter, Inc.
Quest Diagnostics
bioMérieux S.A.
Inova Diagnostics, Inc.
Grifols S.A.
Trinity Biotech plc
DiaSorin S.p.A.
ERBA Diagnostics
Euro Diagnostica
Immco Diagnostics
Adaptive Biotechnologies

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment